Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported higher revenues for the fourth quarter of 2025, which translated into a sharp increase in net income. The company also issued guidance for fiscal 2026.
Fourth-quarter earnings, excluding special items, rose 11% year-over-year to $0.62 per share. On an unadjusted basis, net profit was $1.06 billion or $0.82 per share in Q4, compared to $654 million or $0.49 per share in the same period of 2024.
Revenues of Cardiovascular and Neuroscience, the main operating segments, increased by 7% and 3% respectively. Total revenues grew 4% year-over-year to $8.9 billion during the three months.
The post MDT Earnings: A snapshot of Medtronic’s Q4 2025 report first appeared on AlphaStreet.
—
Blog powered by G6
Disclaimer! A guest author has made this post. G6 has not checked the post. its content and attachments and under no circumstances will G6 be held responsible or liable in any way for any claims, damages, losses, expenses, costs or liabilities whatsoever (including, without limitation, any direct or indirect damages for loss of profits, business interruption or loss of information) resulting or arising directly or indirectly from your use of or inability to use this website or any websites linked to it, or from your reliance on the information and material on this website, even if the G6 has been advised of the possibility of such damages in advance.
For any inquiries, please contact [email protected]
